Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Concept Videos

Pulmonary Tuberculosis I01:29

Pulmonary Tuberculosis I

733
Tuberculosis, often called TB, is a contagious illness primarily caused by Mycobacterium tuberculosis. It mainly affects the lung parenchyma but can also impact other body parts.
Causative Organism
The primary infectious agent causing tuberculosis is Mycobacterium tuberculosis, a slow-growing, acid-fast, aerobic rod that exhibits sensitivity to heat and ultraviolet light. Instances of Mycobacterium bovis and Mycobacterium avium contributing to the development of TB infection are rare.
Mode of...
733
Pulmonary Tuberculosis II01:28

Pulmonary Tuberculosis II

1.2K
Tuberculosis, or TB, is a bacterial infectious disease caused by Mycobacterium tuberculosis. While its primary impact is on the lungs, leading to pulmonary tuberculosis, it can also affect various other organs, a condition referred to as extrapulmonary tuberculosis.
Here is a detailed explanation of its pathophysiology:
Transmission: The process begins when a person inhales droplet nuclei containing M. tuberculosis. These are typically released into the air when an individual with pulmonary or...
1.2K
Pneumonia I: Introduction01:30

Pneumonia I: Introduction

620
Pneumonia is an acute respiratory infection that targets the lungs, specifically the alveoli. These tiny air sacs, essential for oxygen exchange, become engorged with pus and fluid, severely hindering breathing, decreasing oxygen absorption, and causing significant pain and discomfort during respiration.
Risk Factors
Various factors influence the likelihood of developing pneumonia. Age plays a crucial role, with infants, children under two, and individuals over 65 at increased risk due to their...
620
Pneumonia II: Pathophysiology01:29

Pneumonia II: Pathophysiology

2.3K
The pathophysiology of pneumonia involves the following steps:
2.3K
Pulmonary Tuberculosis III01:31

Pulmonary Tuberculosis III

789
Tuberculosis (TB) is a contagious infection primarily affecting the lung parenchyma but which can also affect other body parts. TB can be classified based on disease development, presentation, and the affected anatomical site.
The first classification is based on the development of the disease, and it includes the following categories:
789
Pulmonary Tuberculosis V01:28

Pulmonary Tuberculosis V

460
Medical management of tuberculosis (TB) patients involves a comprehensive approach that includes diagnosis, treatment, and monitoring. The specific strategies can vary depending on the type of tuberculosis (latent or active), the patient's overall health status, and other considerations.
Latent tuberculosis infection occurs when TB bacteria are present in a person's body, but are not causing illness or symptoms. It is not contagious, and preventive treatment is crucial to avoid the...
460

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Associations between migrasome-related genes and long non-coding rnas in glioma and their prognostic relevance to the tumor microenvironment.

IBRO neuroscience reports·2026
Same author

Long-term lessons from MATCH01 macrophage therapy in cirrhosis.

Cell stem cell·2026
Same author

Dose-dependent effects of biochar on low-temperature anammox: reactor performance, community variation, and functional potential.

Bioresource technology·2026
Same author

Correction to "Living Therapeutic Microneedles Integrated with Built-In Metabolic Engines for Autonomous Diabetic Wound Management".

Nano letters·2026
Same author

SLC30A9-mediated mitochondrial zinc homeostasis drives osteosarcoma chemoresistance by suppressing the mtDNA-cGAS-STING pathway.

Life sciences·2026
Same author

Temporal patterns and risk factors of recurrent influenza infection: a population-based epidemiological study.

BMC public health·2026

Related Experiment Video

Updated: Dec 17, 2025

Analysis of 18FDG PET/CT Imaging as a Tool for Studying Mycobacterium tuberculosis Infection and Treatment in Non-human Primates
10:04

Analysis of 18FDG PET/CT Imaging as a Tool for Studying Mycobacterium tuberculosis Infection and Treatment in Non-human Primates

Published on: September 5, 2017

19.1K

Pneumonia caused by Mycobacterium tuberculosis.

Meili Wei1, Yongjie Zhao1, Zhuoyu Qian2

  • 1School of Life Sciences, Bengbu Medical College, Anhui, China.

Microbes and Infection
|June 21, 2020
PubMed
Summary

Rapid diagnosis of acute tuberculous pneumonia (TP) is vital to prevent tuberculosis (TB) transmission. New diagnostic tools and flexible treatments are needed to reduce TP incidence and end the TB epidemic.

Keywords:
Acute tuberculous pneumoniaDiagnosisTherapyTuberculosis

More Related Videos

A 3D Human Lung Tissue Model for Functional Studies on Mycobacterium tuberculosis Infection
10:10

A 3D Human Lung Tissue Model for Functional Studies on Mycobacterium tuberculosis Infection

Published on: October 5, 2015

19.3K
Following in Real Time the Impact of Pneumococcal Virulence Factors in an Acute Mouse Pneumonia Model Using Bioluminescent Bacteria
11:32

Following in Real Time the Impact of Pneumococcal Virulence Factors in an Acute Mouse Pneumonia Model Using Bioluminescent Bacteria

Published on: February 23, 2014

15.4K

Related Experiment Videos

Last Updated: Dec 17, 2025

Analysis of 18FDG PET/CT Imaging as a Tool for Studying Mycobacterium tuberculosis Infection and Treatment in Non-human Primates
10:04

Analysis of 18FDG PET/CT Imaging as a Tool for Studying Mycobacterium tuberculosis Infection and Treatment in Non-human Primates

Published on: September 5, 2017

19.1K
A 3D Human Lung Tissue Model for Functional Studies on Mycobacterium tuberculosis Infection
10:10

A 3D Human Lung Tissue Model for Functional Studies on Mycobacterium tuberculosis Infection

Published on: October 5, 2015

19.3K
Following in Real Time the Impact of Pneumococcal Virulence Factors in an Acute Mouse Pneumonia Model Using Bioluminescent Bacteria
11:32

Following in Real Time the Impact of Pneumococcal Virulence Factors in an Acute Mouse Pneumonia Model Using Bioluminescent Bacteria

Published on: February 23, 2014

15.4K

Area of Science:

  • Medicine
  • Infectious Diseases
  • Pulmonology

Background:

  • Tuberculosis (TB) remains a leading global cause of death, caused by Mycobacterium tuberculosis.
  • Acute tuberculous pneumonia (TP) is a severe form of pulmonary TB.
  • TP can be misdiagnosed as community-acquired pneumonia, leading to treatment delays and disease progression.

Purpose of the Study:

  • To highlight the critical need for rapid and accurate diagnosis of acute TP.
  • To emphasize the importance of developing novel diagnostic technologies for TP.
  • To advocate for flexible therapeutic strategies to combat TP and reduce TB transmission.

Main Methods:

  • This study is a review and synthesis of current knowledge on acute tuberculous pneumonia diagnosis and treatment.
  • It analyzes the challenges in differentiating TP from other pneumonias.
  • It discusses the potential impact of new diagnostic and therapeutic approaches.

Main Results:

  • Delayed diagnosis of acute TP leads to worsened patient outcomes and continued TB transmission.
  • Current diagnostic methods can be insufficient to quickly distinguish TP from other pneumonias.
  • Innovative diagnostic tools and adaptable treatment plans are essential for effective TP management.

Conclusions:

  • Accurate and timely diagnosis of acute TP is crucial for effective TB control.
  • Advancements in diagnostic technologies are necessary to improve TP identification.
  • Implementing flexible therapeutic schemes can significantly reduce TP incidence and contribute to ending the global TB epidemic.